Retraction
Accepted on 09 Sep 2026
Retraction: PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults
in Pediatric Oncology
Retraction
Accepted on 09 Sep 2026
in Pediatric Oncology
Original Research
Accepted on 08 Sep 2026
in Pediatric Oncology
Original Research
Accepted on 07 Sep 2026
in Pediatric Oncology
Systematic Review
Published on 04 Sep 2026
in Pediatric Oncology
Original Research
Published on 03 Sep 2026
in Pediatric Oncology
Systematic Review
Published on 03 Sep 2026
in Pediatric Oncology
Original Research
Published on 01 Sep 2026
in Pediatric Oncology
Case Report
Published on 01 Sep 2026
in Pediatric Oncology
Systematic Review
Accepted on 31 Aug 2026
in Pediatric Oncology
Original Research
Accepted on 31 Aug 2026
in Pediatric Oncology
Original Research
Accepted on 31 Aug 2026
in Pediatric Oncology
Case Report
Accepted on 31 Aug 2026
in Pediatric Oncology
Original Research
Accepted on 28 Aug 2026
in Pediatric Oncology
Original Research
Published on 21 Aug 2026
in Pediatric Oncology
Case Report
Accepted on 17 Aug 2026
in Pediatric Oncology
Original Research
Published on 17 Aug 2026
in Pediatric Oncology
Review
Published on 14 Aug 2026
in Pediatric Oncology
Mini Review
Published on 11 Aug 2026
in Pediatric Oncology
Original Research
Published on 06 Aug 2026
in Pediatric Oncology
Case Report
Published on 05 Aug 2026
in Pediatric Oncology
Case Report
Published on 04 Aug 2026
in Pediatric Oncology
Case Report
Published on 31 Jul 2026
in Pediatric Oncology
Case Report
Published on 30 Jul 2026
in Pediatric Oncology
Original Research
Published on 29 Jul 2026
in Pediatric Oncology